Leadiant Biosciences is managed by a team of executives with exceptional experience in the all different aspects of the pharmaceutical business, with special expertise in the development, registration and commercialization of rare disease products.
Dr. Gama da Silva is the Chief Executive Officer at Leadiant Biosciences, Ltd., where he is responsible for managing the group’s international business (ex-USA and Canada). Dr. Gama da Silva brings more than 20 years of experience in the pharmaceutical industry having held different positions of increasing responsibility at global companies such as Novartis, AstraZeneca, FAES Group, Bayer and Octapharma.
Dr. Gama da Silva received his M.D. from Lisbon University Medical School. He is a consultant in Allergology and Clinical Immunology.
Dr. Verma is the Chief Medical Officer at Leadiant Biosciences Ltd. She was appointed CMO in 2016 after serving two years as International Medical Director. As Chief Medical Officer, she provides the medical leadership to Leadiant Biosciences and its international (ex-USA and Canada) operations. Dr Verma brings invaluable experience from her long clinical career in surgery, respiratory and renal medicine in the National Health Service (NHS) complimented by a decade long experience in industry as a pharmaceutical physician spanning a wide variety of therapeutic areas in positions of increasing seniority.
Dr. Verma received her Medical degree from the University of London, and a Master’s in Surgical Technology from Imperial College London. She is also a qualified Dental Surgeon, and a Fellow of the Royal College of Surgeons, England. Dr Verma was awarded a Global Executive MBA from TRIUM, a partnership of London School of Economics, New York University and HEC (École des hautes études commerciales de Paris). She has also completed her Global Clinical Research Scholar Training (with distinction) from Harvard Medical School.
Dr. Adejuyigbe is the Head of Regulatory Affairs and Pharmacovigilance at Leadiant Biosciences Ltd. She is responsible for the overall regulatory strategy and operations, from development through post- marketing in Europe and the rest of the world, to management and coordination of the Pharmacovigilance system. Dr. Adejuyigbe joined the company in 2013 as manager of regulatory affairs and quality assurance.
Prior to joining Leadiant Biosciences Ltd., Dr. Adejuyigbe worked for several years at the Medicines and Healthcare products Regulatory Agency (MHRA) in London as a pharmaceutical assessor, and then moved on to senior roles in the regulatory affairs department at GlaxoSmithKline in London and Genzyme in the Netherlands.
Dr. Adejuyigbe is a registered pharmacist and earned her doctorate degree in pharmacy from Kings College London, UK where she specialised in the development of multi-mode optical spectroscopy of proteins and peptides.
Mr. Teixeira da Silva is Head of International Marketing and Market Access at Leadiant Biosciences Ltd. He is responsible for the overall market access and marketing strategy as well as commercial operations from development through post-marketing in Europe and the rest of the world.
Mr. Teixeira da Silva joined the company in 2014 as Head of Marketing with the responsibility to prepare the company to commercialize its new products.
Prior to joining Leadiant Biosciences Ltd., Mr. Teixeira da Silva has held positions at Bayer Pharmaceuticals (USA) as a Global Brand manager, as well as several regional marketing and country roles within Bayer, Astellas and AstraZeneca. His background includes experience in multiple therapeutic areas including Oncology, Transplantation, CNS and Respiratory.
Mr. Teixeira da Silva is a biologist and earned his degree in Biology from Universidade de Evora (Portugal), a master’s degree in Marketing from Instituto Superior de Economia e Gestao (ISEG, Portugal). He holds an MBA from universities Católica-Lisbon and Nova in partnership with the MIT Sloan School of Management.
